TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8756387

Group type: EXPERIMENTAL
Intervention: Definitive surgery (surgery alone)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Postoperative irradiation
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 244

Group type: COMPARATOR
Intervention: Irradiation alone (control group)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Complete resection (radical or wide margin)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Incomplete resection (marginal or intralesional margin)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Irradiation after incomplete surgery
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Histologic response (good)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Histologic response (poor)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Surgical margins (radical, wide, marginal, intralesional)
Number of subjects: 244
Study: 1879246

Group type: EXPERIMENTAL
Intervention: Surfactant treatment (SF‐RI 1)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 7038925

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole standard dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole high-dose schedule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chloroquine standard course
Number of subjects: 0
Study: 30585388

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 984

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 984
Study: 29498155

Group type: EXPERIMENTAL
Intervention: Data-driven intervention asking providers to self-identify opioid prescribing practices and providing actual prescribing data
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 109
Study: 28846646

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Health-education (HE)
Number of subjects: 113
Study: 24812024

Group type: EXPERIMENTAL
Intervention: Naltrexone (25, 50, or 100mg) or placebo with smoking cessation counseling and 21 mg nicotine patch daily
Number of subjects: 348
Study: 24431257

Group type: EXPERIMENTAL
Intervention: Kinesiology Taping (KT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no Kinesiology Taping)
Number of subjects: 26
Study: 20643882

Group type: EXPERIMENTAL
Intervention: Rhythmic auditory stimulation (RAS)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 10
Study: 18390968

Group type: EXPERIMENTAL
Intervention: AZD6244 (50% MTD, 100 mg bid)
Number of subjects: 57

Group type: COMPARATOR
Intervention: AZD6244 (MTD, 200 mg bid)
Number of subjects: 57
Study: 16624830

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich diet (cruciferous vegetables, no supplementation)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Normal isocaloric diet (adequate fruits and vegetables)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Supplementation of flavonoids (green tea and soy products)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (normal isocaloric diet)
Number of subjects: 90
Study: 12682771

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle (PFM) exercises
Number of subjects: 28
Study: 11714001

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (HF)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (CFR)
Number of subjects: 480
Study: 8974898

Group type: EXPERIMENTAL
Intervention: 3 D-video system
Number of subjects: 76

Group type: COMPARATOR
Intervention: 2 D-video system
Number of subjects: 76
Study: 8272201

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) administered as subcutaneous injection of 3 million units 5 times a week for 8 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3826277

Group type: EXPERIMENTAL
Intervention: Timolol maleate (0.5%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High cognitive demand
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low cognitive demand
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beta-antagonism
Number of subjects: 20
Study: 29713151

Group type: EXPERIMENTAL
Intervention: Empowerment educational intervention
Number of subjects: 464

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 464
Study: 27756441

Group type: EXPERIMENTAL
Intervention: Cream-type adhesive
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Powder-type adhesive
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (isotonic sodium chloride solution)
Number of subjects: 300
Study: 24996807

Group type: EXPERIMENTAL
Intervention: Confirmed malaria-related fever
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: CD4 lymphocytes
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment started before inclusion
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: History of symptomatic malaria in early pregnancy
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Febrile episodes attributable to malaria
Number of subjects: 432
Study: 24942930

Group type: EXPERIMENTAL
Intervention: Friend support for healthy eating
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Coworker support for healthy eating
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Family support for physical activity
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Family social undermining for healthy eating
Number of subjects: 633
Study: 23018299

Group type: EXPERIMENTAL
Intervention: Hyperventilation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal ventilation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hypoventilation
Number of subjects: 30
Study: 21046483

Group type: EXPERIMENTAL
Intervention: Bicarbonate supplementation (67.5 mmol/day of potassium bicarbonate or sodium bicarbonate)
Number of subjects: 153

Group type: COMPARATOR
Intervention: No-bicarbonate groups (67.5 mmol/day of placebo or potassium chloride)
Number of subjects: 153
Study: 17692153

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg daily for 6 weeks, increased to 20 mg after 6 weeks, then to 40 mg after 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: atorvastatin 20 mg daily for 6 weeks, increased to 40 mg after 6 weeks, then to 80 mg after 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: rosuvastatin and atorvastatin (both groups)
Number of subjects: 68
Study: 16254818

Group type: EXPERIMENTAL
Intervention: Bonistein 30 mg once daily for 14 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bonistein 60 mg once daily for 14 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bonistein 120 mg once daily for 14 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bonistein (all doses)
Number of subjects: 30
Study: 12121609

Group type: EXPERIMENTAL
Intervention: One-stage surgery with two-piece implants (group A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Two-stage surgery with two-piece implants (group B, control)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: One-stage surgery with one-piece implants (group C)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 82
Study: 10468965

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) replacement therapy (0.25 IU/Kg/week, 0.125 IU/kg/week for the first four weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) replacement therapy
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Open GH treatment after placebo
Number of subjects: 35
Study: 8862492

Group type: EXPERIMENTAL
Intervention: 50 mg/day clomiphene citrate for 3 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: 50 mg/day clomiphene citrate for 5 days
Number of subjects: 28
Study: 1363657

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Zolpidem 10-20 mg
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg (in elderly)
Number of subjects: 781

Group type: COMPARATOR
Intervention: Zolpidem
Number of subjects: 781
Study: 6092317

Group type: EXPERIMENTAL
Intervention: Sultamicillin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin
Number of subjects: 52
Study: 29562794

Group type: EXPERIMENTAL
Intervention: Postdates induction (≥41 weeks)
Number of subjects: 854

Group type: COMPARATOR
Intervention: Term induction (37–40w6d)
Number of subjects: 854
Study: 30499380

Group type: EXPERIMENTAL
Intervention: Intervention group (digital stethoscope and HHE)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (standard stethoscope only)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 8

Group type: COMPARATOR
Intervention: Difference between control and intervention groups
Number of subjects: 8
Study: 26647373

Group type: EXPERIMENTAL
Intervention: Moderate/significant-CVD group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Correlation between serum-SAA and HDL3-SAA
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Correlation between HDL3-SAA and HDL3-LCAT activity
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Correlation between CVD-burden and serum-SAA
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Correlation between CVD-burden and HDL3-SAA
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Correlation between CVD-burden and HDL3-LCAT activity
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: HDL3-SAA
Number of subjects: 240
Study: 24961493

Group type: EXPERIMENTAL
Intervention: Ivabradine in patients with SBP <115 mmHg
Number of subjects: 2110

Group type: EXPERIMENTAL
Intervention: Ivabradine in patients with 115≤ SBP <130 mmHg
Number of subjects: 2110

Group type: EXPERIMENTAL
Intervention: Ivabradine in patients with SBP ≥130 mmHg
Number of subjects: 2110

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 2110
Study: 22746950

Group type: EXPERIMENTAL
Intervention: Factorial morphspaces
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blended morphspaces
Number of subjects: 0
Study: 21041812

Group type: EXPERIMENTAL
Intervention: Lipid meal
Number of subjects: 10
Study: 17485161

Group type: EXPERIMENTAL
Intervention: BCG 27 mg
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: BCG 13.5 mg
Number of subjects: 430

Group type: COMPARATOR
Intervention: MMC 30 mg
Number of subjects: 430
Study: 15517239

Group type: EXPERIMENTAL
Intervention: Peak Systolic Velocity (PSV) cutpoint of 200 cm/s for increased TCD surveillance
Number of subjects: 1937

Group type: EXPERIMENTAL
Intervention: PSV cutpoint of 250 cm/s for consideration of chronic transfusion treatment
Number of subjects: 1937

Group type: COMPARATOR
Intervention: TAMM velocity
Number of subjects: 1937

Group type: COMPARATOR
Intervention: End Diastolic Velocity (EDV)
Number of subjects: 1937
Study: 12092017

Group type: EXPERIMENTAL
Intervention: Hands-on method
Number of subjects: 1161

Group type: COMPARATOR
Intervention: Hands-poised method
Number of subjects: 1161
Study: 9454524

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 2078

Group type: EXPERIMENTAL
Intervention: Sulfonylurea
Number of subjects: 2078

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2078

Group type: COMPARATOR
Intervention: Diet-controlled group
Number of subjects: 2078

Group type: COMPARATOR
Intervention: Primary diet failure group
Number of subjects: 2078

Group type: EXPERIMENTAL
Intervention: Ultralente insulin
Number of subjects: 2078
Study: 7614164

Group type: EXPERIMENTAL
Intervention: Topical podophyllum resin 25% solution
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 10
Study: 1535495

Group type: EXPERIMENTAL
Intervention: Balneotherapy
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Underwater traction bath
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Underwater massage
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 158
Study: 6571946

Group type: EXPERIMENTAL
Intervention: Intermediate-dose methotrexate plus intrathecal methotrexate
Number of subjects: 506

Group type: COMPARATOR
Intervention: Cranial irradiation plus intrathecal methotrexate
Number of subjects: 506
Study: 31655891

Group type: EXPERIMENTAL
Intervention: 3D Phase‐Sensitive Inversion Recovery (PSIR)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional dataset (3D Short Tau Inversion Recovery (STIR) and T2‐weighted imaging)
Number of subjects: 54
Study: 29728889

Group type: EXPERIMENTAL
Intervention: Flapless technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flap technique
Number of subjects: 20
Study: 25286894

Group type: EXPERIMENTAL
Intervention: Prior exhaustive training (PE)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Traditional training (TR)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Untrained control (CO)
Number of subjects: 27
Study: 24970601

Group type: EXPERIMENTAL
Intervention: Therapist-guided exposure (T+)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Self-guided exposure (T-)
Number of subjects: 42
Study: 22369224

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatments for alcohol-dependent women
Number of subjects: 181
Study: 19172031

Group type: EXPERIMENTAL
Intervention: Topical finasteride (1% gel)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral finasteride (1 mg tablet)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both interventions (topical and oral finasteride)
Number of subjects: 45
Study: 17426085

Group type: EXPERIMENTAL
Intervention: Diane(35) Diario (35 microg of ethinyl‐estradiol plus 2 mg of cyproterone acetate)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Metformin (850 mg twice daily)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Diane(35) Diario
Number of subjects: 34

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Diane(35) Diario and Metformin
Number of subjects: 34
Study: 16322169

Group type: EXPERIMENTAL
Intervention: Behavioral and nutrition intervention (BEH)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual care control condition (CTL)
Number of subjects: 10
Study: 12006162

Group type: EXPERIMENTAL
Intervention: Ginkgo (60 mg TID)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 26
Study: 10220205

Group type: EXPERIMENTAL
Intervention: 100 mg Q10 daily for 3 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 7637151

Group type: EXPERIMENTAL
Intervention: 25g glucose infusion in an hour (glucose group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: No glucose infusion (control group)
Number of subjects: 74
Study: 2617243

Group type: EXPERIMENTAL
Intervention: Cold cardioplegic solution allowed to pass through the lungs (n = 27)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cold cardioplegic solution evacuated via right atrium (n = 28)
Number of subjects: 55
Study: 1086714

Group type: EXPERIMENTAL
Intervention: methotrexate-citrovorum factor rescue plus cyclophosphamide
Number of subjects: 35

Group type: COMPARATOR
Intervention: methotrexate-citrovorum factor rescue alone
Number of subjects: 35
Study: 31464945

Group type: EXPERIMENTAL
Intervention: Inhalation sedation with acclimatization visit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhalation sedation without acclimatization visit
Number of subjects: 0
Study: 28159196

Group type: EXPERIMENTAL
Intervention: Droxidopa
Number of subjects: 0
Study: 26057627

Group type: EXPERIMENTAL
Intervention: Group A (48 weeks treatment with 1.5 μg/kg Pegylated Interferon alpha and 800-1400 mg Ribavirin)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Group B (36 weeks treatment with 1.5 μg/kg Pegylated Interferon alpha and 800-1400 mg Ribavirin)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Historical control group (SVR 70%)
Number of subjects: 99
Study: 23076431

Group type: EXPERIMENTAL
Intervention: N(G)‐nitro‐l‐arginine methyl ester hydrochloride (L‐NAME, 20 mM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anaesthetics (EMLA) cream (2.5% lidocaine and 2.5% prilocaine)
Number of subjects: 17
Study: 21568191

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention (8-week group intervention, weekly 2-hour sessions)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 21
Study: 19781410

Group type: EXPERIMENTAL
Intervention: EPC capturing stent
Number of subjects: 2560

Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 2560

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES)
Number of subjects: 2560
Study: 17070146

Group type: EXPERIMENTAL
Intervention: Oral ivabradine (5 mg twice daily for 2 weeks then target dose of 7.5 mg twice daily)
Number of subjects: 9650

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9650
Study: 15799170

Group type: EXPERIMENTAL
Intervention: Simvastatin 20mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine group (placebo)
Number of subjects: 50
Study: 11774942

Group type: EXPERIMENTAL
Intervention: Telephone survey
Number of subjects: 100

Group type: COMPARATOR
Intervention: E-mail survey
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard mail survey
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonresponders (contacted by telephone)
Number of subjects: 100

Group type: COMPARATOR
Intervention: All groups (telephone, e-mail, standard mail)
Number of subjects: 100
Study: 9245674

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including a UVR reduction curriculum and home-based activities for children and parents.
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control condition (no specific intervention details provided).
Number of subjects: 169
Study: 8343267

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 121

Group type: COMPARATOR
Intervention: Latamoxef
Number of subjects: 121
Study: 3525829

Group type: EXPERIMENTAL
Intervention: Stress self-help package administered by general practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing general practitioner treatment without the package
Number of subjects: 0
Study: 31543407

Group type: EXPERIMENTAL
Intervention: Fast adaptation (10 hours wear from the first day)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Gradual adaptation (4 hours on the first day, increasing by 2 hours daily until reaching 10 hours)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Fast adaptation silicone-hydrogel
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Fast adaptation hydrogel
Number of subjects: 74
Study: 28921624

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose, then 90 mg twice daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 60
Study: 27267068

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mononuclear cells (BM-MNC) treatment (early, administered 5 to 7 days after AMI)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Bone marrow-derived mononuclear cells (BM-MNC) treatment (late, administered 3 to 4 weeks after AMI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (open-labeled)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups (combined clinical end point)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups (1-year mortality)
Number of subjects: 200
Study: 23583566

Group type: EXPERIMENTAL
Intervention: FBC 9/320 μg bid
Number of subjects: 66

Group type: COMPARATOR
Intervention: SFC 50/250 μg bid
Number of subjects: 66
Study: 23577078

Group type: EXPERIMENTAL
Intervention: Brown beans evening meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: White wheat bread (WWB) evening meal
Number of subjects: 16
Study: 20390820

Group type: EXPERIMENTAL
Intervention: Coaching group (in vivo feedback)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No coaching group (control)
Number of subjects: 60
Study: 18547996

Group type: EXPERIMENTAL
Intervention: Erythropoiesis stimulating agents (epoetin) treatment in anemic patients (23 patients)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Anemic patients (50 patients)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-anemic patients (50 patients)
Number of subjects: 100
Study: 15641007

Group type: EXPERIMENTAL
Intervention: ICEX TSB socket
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional PTB socket
Number of subjects: 26
Study: 12815694

Group type: EXPERIMENTAL
Intervention: N-acetylaspartate (NAA) levels in MS patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) levels in MS patients
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Choline (Cho) levels in MS patients
Number of subjects: 11

Group type: COMPARATOR
Intervention: Choline (Cho) levels in controls
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Overall metabolite levels comparison
Number of subjects: 11
Study: 10589367

Group type: EXPERIMENTAL
Intervention: Combination cyclosporine and chloroquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antimalarials
Number of subjects: 0
Study: 8724305

Group type: EXPERIMENTAL
Intervention: Visible electromagnetic fields (light condition; mean 4750 lux, SD 2337 lux)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonvisible electromagnetic fields (no light condition)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Visible electromagnetic fields (light condition)
Number of subjects: 14
Study: 1884543

Group type: EXPERIMENTAL
Intervention: Single-agent adjuvant chemotherapy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Six-agent, alternating, adjuvant postoperative chemotherapy
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Limb-salvage operations
Number of subjects: 74

Group type: COMPARATOR
Intervention: Amputation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Limb-salvage operations vs Amputation
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Alternating, multiagent, adjuvant chemotherapy
Number of subjects: 74
Study: 6614524

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 3% chloroprocaine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:200,000 epinephrine
Number of subjects: 54